View in EDS HTML Full Text PDF Full Text

Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux.

Saved in:
Bibliographic Details
Title: Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux.
Authors: Zhang, Ye1 (AUTHOR), Qiu, Jian-Ge1,2 (AUTHOR), Wang, Wei2 (AUTHOR), Sun, Fan-Li2 (AUTHOR), Wang, Xue2 (AUTHOR), Liu, Wen-Jing3 (AUTHOR), Jia, Xiao-Yu2 (AUTHOR), Ji, Hongbin4 (AUTHOR), Wang, Lin1,2 (AUTHOR) wanglinzz@zzu.edu.cn, Jiang, Bing-Hua1 (AUTHOR) binghjiang@zzu.edu.cn
Source: Experimental Hematology & Oncology. 2/26/2025, Vol. 14 Issue 1, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21623619
DOI:10.1186/s40164-025-00620-z